by John Weeks, Publisher/Editor of The Integrator Blog News & Reports

Naturopathic Doctors, Integrative Medicine Consortium and Alliance for Natural Health Weigh in on Compounding Pharmacies

Mike  Jawer, the director of government relations with the American Association of Naturopathic Physicians (AANP) shares that the AANP along with the Integrative Medicine Consortium and the Alliance for Natural Health have each submitted comments to the FDA States Jawer: “It’s a complicated issue but the stakes are high – namely, the continued availability of compounded drugs – especially as dispensed for patients in the office.” In a notice to members, the AANP stated that via “a collaboration with McGuff, a well-respected compounding firm that has been very active on this issue, our ND volunteers documented the clinical need for 43 ingredients that are essential in the compounded drugs that naturopathic patients are treated with.” The AANP asked for additional time to fulfill on the burdensome application requirements to document the clinical need for another large group of ingredients.

by John Weeks, Publisher/Editor of The Integrator Blog News & Reports

Naturopathic Doctors, Integrative Medicine Consortium and Alliance for Natural Health Weigh in on Compounding Pharmacies

Mike  Jawer, the director of government relations with the American Association of Naturopathic Physicians (AANP) shares that the AANP along with the Integrative Medicine Consortium and the Alliance for Natural Health have each submitted comments to the FDA States Jawer: “It’s a complicated issue but the stakes are high – namely, the continued availability of compounded drugs – especially as dispensed for patients in the office.” In a notice to members, the AANP stated that via “a collaboration with McGuff, a well-respected compounding firm that has been very active on this issue, our ND volunteers documented the clinical need for 43 ingredients that are essential in the compounded drugs that naturopathic patients are treated with.” The AANP asked for additional time to fulfill on the burdensome application requirements to document the clinical need for another large group of ingredients.